Achilles B. Kintiroglou
Known title: SVP, General CounselCIK: 0001806189
Associated companies
Transaction History
| ASIX | ▼ Sell | Tax Withholding | 8,008 | $140K | 2/28/2026 | View on chart |
| ASIX | ▲ Buy | Grant | 28,106 | $500K | 2/26/2026 | View on chart |
| ASIX | ▼ Sell | Open Market | 577 | $12K | 10/3/2025 | View on chart |
| ASIX | ▼ Sell | Open Market | 571 | $12K | 9/2/2025 | View on chart |
| ASIX | ▼ Sell | Open Market | 571 | $12K | 8/1/2025 | View on chart |
| ASIX | ▼ Sell | Open Market | 571 | $14K | 7/2/2025 | View on chart |
| ASIX | ▼ Sell | Open Market | 571 | $14K | 6/2/2025 | View on chart |
| ASIX | ▼ Sell | Open Market | 3,237 | $69K | 5/1/2025 | View on chart |
| ASIX | ▼ Sell | Open Market | 4,000 | $89K | 4/1/2025 | View on chart |
| ASIX | ▼ Sell | Open Market | 4,000 | $111K | 3/3/2025 | View on chart |
| ASIX | ▲ Buy | Grant | 15,856 | $0 | 2/28/2025 | View on chart |
| ASIX | ▼ Sell | Tax Withholding | 4,731 | $131K | 2/28/2025 | View on chart |
| ASIX | ▼ Sell | Open Market | 363 | $11K | 11/1/2024 | View on chart |
| ASIX | ▼ Sell | Open Market | 350 | $11K | 10/1/2024 | View on chart |
| ASIX | ▼ Sell | Open Market | 350 | $10K | 9/3/2024 | View on chart |
| ASIX | ▼ Sell | Open Market | 350 | $10K | 8/1/2024 | View on chart |
| ASIX | ▼ Sell | Open Market | 350 | $8K | 7/1/2024 | View on chart |
| ASIX | ▼ Sell | Open Market | 350 | $8K | 6/3/2024 | View on chart |
| ASIX | ▼ Sell | Open Market | 3,661 | $92K | 5/1/2024 | View on chart |
| ASIX | ▼ Sell | Open Market | 3,900 | $108K | 4/1/2024 | View on chart |
| ASIX | ▼ Sell | Open Market | 100 | $3K | 4/1/2024 | View on chart |
| ASIX | ▼ Sell | Open Market | 4,000 | $111K | 3/1/2024 | View on chart |
| ASIX | ▲ Buy | Grant | 15,047 | $0 | 2/28/2024 | View on chart |
| ASIX | ▼ Sell | Tax Withholding | 7,411 | $203K | 2/28/2024 | View on chart |
| ASIX | ▲ Buy | Grant | 16,046 | $0 | 2/28/2024 | View on chart |
| ASIX | ▼ Sell | Tax Withholding | 3,785 | $105K | 2/24/2024 | View on chart |
| ASIX | ▼ Sell | Open Market | 500 | $15K | 1/2/2024 | View on chart |
| ASIX | ▼ Sell | Open Market | 1,000 | $30K | 12/18/2023 | View on chart |
| ASIX | ▼ Sell | Open Market | 500 | $15K | 10/2/2023 | View on chart |
| ASIX | ▼ Sell | Open Market | 500 | $17K | 9/1/2023 | View on chart |
| ASIX | ▼ Sell | Open Market | 3,335 | $132K | 8/1/2023 | View on chart |
| ASIX | ▼ Sell | Open Market | 3,335 | $116K | 7/3/2023 | View on chart |
| ASIX | ▼ Sell | Open Market | 3,335 | $118K | 6/12/2023 | View on chart |
| ASIX | ▼ Sell | Tax Withholding | 14,792 | $609K | 2/28/2023 | View on chart |
| ASIX | ▲ Buy | Grant | 4,095 | $0 | 2/28/2023 | View on chart |
| ASIX | ▲ Buy | Grant | 30,200 | $0 | 2/28/2023 | View on chart |
| ASIX | ▼ Sell | Tax Withholding | 3,733 | $153K | 2/26/2023 | View on chart |
| ASIX | ▼ Sell | Tax Withholding | 1,905 | $78K | 2/24/2023 | View on chart |
| ASIX | ▲ Buy | Grant | 816 | $0 | 2/28/2022 | View on chart |
| ASIX | ▼ Sell | Tax Withholding | 819 | $32K | 2/28/2022 | View on chart |
| ASIX | ▲ Buy | Grant | 3,512 | $0 | 2/28/2022 | View on chart |
| ASIX | ▼ Sell | Tax Withholding | 1,823 | $64K | 2/24/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
AdvanSix Featured in Chemical Stocks With Natural Gas Cost Edge
AdvanSix (ASIX) was included in a recent article highlighting three US chemical stocks that benefit from lower natural gas costs. This cost advantage is relevant to the company's production expenses in the specialty chemicals sector. The stock is currently trading below its average analyst target price, with a 52-week range extending from $14.10 to $26.73.
AdvanSix Featured in Chemical Stocks With Natural Gas Cost Edge. AdvanSix (ASIX) was included in a recent article highlighting three US chemical stocks that benefit from lower natural gas costs. This cost advantage is relevant to the company's production expenses in the specialty chemicals sector. The stock is currently trading below its average analyst target price, with a 52-week range extending from $14.10 to $26.73.